The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...

The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled today its proprietary, breakthrough sequencing by expansion (SBX) technology, ...

Edward Haynes reveals how advanced sequencing technologies are assisting food companies in their mission to deliver quality ...

SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, immun ...

GeneDx specializes in whole genome sequencing. That involves looking at about 20,000 genes that make up a genome, the instructions to build and sustain a human. More common multi-gene panels ...

A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...

President and CEO Katherine Stueland stated that GeneDx achieved significant milestones in 2024, including surpassing $95 million in Q4 revenue and expanding gross margins to 70%. She highlighted the ...

Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...